/Companies

ReAx Biotechnologies

2 known investors

Find your way into ReAx Biotechnologies

Sign up to see every warm intro you have to ReAx Biotechnologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ReAx Biotechnologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Reaxbio develops a chemoproteomics platform that identifies and targets novel protein sites for drug discovery across disease-relevant biological contexts. The platform enables small molecule discovery for virtually any protein using proprietary chemical tools and high-throughput screening capabilities.

Founders & leadership

JMJeff Montgomery
Jeff MontgomeryCo-Founder & Principal ScientistJeff Montgomery is a chemical biologist with expertise in peptides, proteins, and assay development. He founded Reaxbio, which develops chemoproteomics platforms for drug discovery.

Investors · 2

Frequently asked questions

What does ReAx Biotechnologies do?
Reaxbio develops a chemoproteomics platform that identifies and targets novel protein sites for drug discovery across disease-relevant biological contexts. The platform enables small molecule discovery for virtually any protein using proprietary chemical tools and high-throughput screening capabilities.
Who founded ReAx Biotechnologies?
ReAx Biotechnologies was founded by Jeff Montgomery.
Who are ReAx Biotechnologies's investors?
ReAx Biotechnologies's investors include OMX Ventures, Portal Innovations.